In January 2023, the FDA approved Airsupra (albuterol/budesonide) as the first rescue inhaler that combines a bronchodilator with an anti-inflammatory corticosteroid — a significant advance for the estimated 25 million Americans living with asthma. Traditional rescue inhalers like ProAir and Ventolin deliver only albuterol, which opens airways quickly but does nothing to address the underlying inflammation driving an asthma attack. Airsupra tackles both at once. The catch? The Airsupra inhaler cost runs $250 to $400 without insurance, a stark contrast to the $25 to $70 price of generic albuterol inhalers. Here’s what you need to know to manage that cost. For more on navigating medication prices, see our healthcare costs guide.
Airsupra Retail Pricing Without Insurance
Airsupra is manufactured by AstraZeneca and comes as a pressurized metered-dose inhaler containing 180 mcg of albuterol and 160 mcg of budesonide per actuation. Each inhaler provides approximately 180 inhalations. Without insurance or discount programs, typical cash prices at major pharmacies are:
- CVS Pharmacy: $350 to $400
- Walgreens: $320 to $380
- Walmart Pharmacy: $280 to $350
- Costco Pharmacy: $250 to $310
- Independent pharmacies: $260 to $340
Prices fluctuate by location and are subject to change. These figures represent the cash price for one inhaler, and most patients use one to two inhalers per month depending on the frequency of rescue use. The CMS has not yet published benchmark pricing data specific to Airsupra given its relatively recent market entry.
Brand vs. Generic: Are There Cheaper Alternatives?
No generic version of Airsupra exists as of early 2026. The combination of albuterol and budesonide in a single rescue inhaler is unique to this product, and patent protection will prevent generic competition for several years.
However, Airsupra is not the only option for asthma rescue. Generic albuterol inhalers (ProAir HFA generic, Ventolin HFA generic) cost $25 to $70 per inhaler and remain the standard of care for acute bronchospasm relief. The key difference is clinical: Airsupra was studied in the MANDALA trial, published in the New England Journal of Medicine, which found a 27% reduction in the risk of severe asthma exacerbations compared with albuterol alone. For patients with frequent exacerbations or poorly controlled persistent asthma, that reduction translates to fewer ER visits, fewer oral steroid courses, and potentially fewer hospitalizations.
Your pulmonologist or allergist can help determine whether Airsupra’s clinical advantages justify the higher cost for your specific asthma severity and control level. For patients with mild, well-controlled asthma who rarely use a rescue inhaler, generic albuterol remains a reasonable and cost-effective choice.
Airsupra Cost With Insurance
Commercial insurance coverage for Airsupra is expanding but inconsistent. Most large insurers have added it to their formularies, typically at Tier 3 (preferred brand) with copays of $40 to $75 or Tier 4 (non-preferred brand) with copays of $75 to $150. Some plans apply coinsurance of 20% to 40% rather than a flat copay, which on a $350 inhaler means $70 to $140 per fill.
Prior authorization requirements vary. Some insurers require documentation that the patient has uncontrolled asthma despite an appropriate maintenance regimen, while others cover it without restrictions. Step therapy — requiring failure of a standard albuterol inhaler first — is uncommon since Airsupra fills a distinct clinical role, but it does occur with some plans.
Medicare Part D covers Airsupra on most formularies, with cost-sharing that depends on the specific plan’s tier structure and your phase of coverage (deductible, initial coverage, coverage gap, or catastrophic). Under the Inflation Reduction Act, Medicare Part D out-of-pocket costs are capped at $2,000 per year starting in 2025, which limits exposure for beneficiaries filling expensive inhalers alongside other medications. Medicare beneficiaries should check their plan’s formulary through the Medicare Plan Finder tool.
AstraZeneca Savings Programs
AstraZeneca offers a copay savings card for Airsupra that can reduce the cost to as low as $0 for eligible commercially insured patients, with a maximum savings of $400 per 30-day fill. The program is available to patients with commercial insurance who have a valid Airsupra prescription and are not enrolled in any federal or state government healthcare program.
For uninsured patients, AstraZeneca’s AZ&Me Patient Assistance Program may provide Airsupra at no cost. Eligibility is typically based on household income (generally at or below 400% of the federal poverty level), lack of prescription drug coverage, and US residency. The application requires income documentation, prescription information, and your doctor’s signature. Processing time is usually 4 to 6 weeks.
A bridge supply of up to 30 days may be available while the full application is processed, ensuring patients don’t go without needed medication. Contact AZ&Me directly at 1-800-292-6363 or through the program’s website to start the application process.
Pharmacy Discount Cards and Other Savings
GoodRx, SingleCare, and RxSaver all offer discount coupons for Airsupra that can reduce the cash price by 10% to 30%. GoodRx pricing for Airsupra typically shows $220 to $320 depending on the pharmacy, which represents a meaningful savings over the retail cash price. Always compare the discount card price with your insurance copay to determine which route saves more.
Additional strategies for reducing inhaler costs include using mail-order pharmacies, which sometimes offer lower per-unit pricing than retail; asking your doctor for samples (AstraZeneca provides samples to many prescribers); and checking whether your employer’s pharmacy benefits include a specialty drug discount tier. Some states also run pharmaceutical assistance programs that supplement coverage for residents who fall into coverage gaps.
If cost remains prohibitive, discuss the situation openly with your prescriber. Asthma management is highly individualized, and your doctor may identify a combination strategy — for example, using Airsupra selectively during high-risk periods and generic albuterol at other times — that balances clinical benefit with affordability.
Tips for Getting the Most From Your Airsupra Prescription
Proper inhaler technique directly affects both the medication’s effectiveness and how long each inhaler lasts. Shake the inhaler well for 5 seconds before each use. Exhale fully, place the mouthpiece between your teeth, and close your lips around it. Begin a slow, deep breath and press the canister at the start of your inhalation. Hold your breath for 10 seconds, then exhale slowly. If a second inhalation is prescribed, wait 30 to 60 seconds between puffs.
Prime the inhaler before first use (4 test sprays into the air) and reprime if it hasn’t been used in more than 7 days (1 test spray). Keep track of your dose count — Airsupra has a built-in dose counter, but tracking usage in a log helps you anticipate when a refill is needed. Running out mid-asthma attack is both dangerous and costly if it leads to an ER visit.
Store the inhaler at room temperature with the mouthpiece cap in place. Clean the mouthpiece weekly by running warm water through the opening for 30 seconds and air-drying completely before the next use. A clogged mouthpiece reduces the amount of medication reaching your lungs, which wastes doses and reduces effectiveness.
Talk to your doctor about an Asthma Action Plan that specifies when to use Airsupra versus your maintenance inhaler, when to increase controller medications during a flare, and when to seek urgent or emergency care. The National Heart, Lung, and Blood Institute provides free Asthma Action Plan templates that you and your doctor can customize together.
Understanding the Value Proposition
Airsupra’s price premium over generic albuterol is substantial, but the clinical context matters. Severe asthma exacerbations are expensive: an ER visit for asthma costs $1,500 to $3,000 on average, and an asthma hospitalization runs $10,000 to $20,000 according to the CDC. If Airsupra’s 27% reduction in severe exacerbation risk prevents even one ER visit per year, the medication more than pays for itself — particularly for patients with a history of frequent exacerbations.
That said, cost-effectiveness depends on individual risk. A patient who uses a rescue inhaler once or twice a month with stable asthma receives less absolute benefit than a patient who uses rescue medication daily with frequent flares. Your prescriber can help assess where you fall on this spectrum.
Frequently Asked Questions
Is Airsupra better than a regular albuterol inhaler?
For patients with persistent asthma, clinical trials show Airsupra reduces severe exacerbations by 27% compared with albuterol alone. The added budesonide addresses inflammation that albuterol cannot. For patients with very mild or exercise-induced asthma, the clinical advantage may not justify the cost difference. Discuss your asthma severity with your doctor.
Can I use Airsupra as my only asthma medication?
Airsupra is FDA-approved as a rescue inhaler for patients aged 18 and older with asthma. Current guidelines still recommend controller medications (inhaled corticosteroids, long-acting bronchodilators) for persistent asthma. Airsupra is not a replacement for daily controller therapy in most patients, though research on anti-inflammatory reliever strategies continues to evolve.
Does GoodRx work for Airsupra?
Yes. GoodRx coupons can reduce the cash price to approximately $220 to $320 depending on the pharmacy. This is a useful option for uninsured patients or those whose insurance copay exceeds the discount card price. Prices are updated regularly, so check GoodRx the day you plan to fill your prescription.
Will a generic Airsupra be available soon?
Not in the near term. Airsupra’s combination formulation is protected by patents, and no generic applications are publicly known as of early 2026. Generic availability is likely several years away. In the meantime, the manufacturer copay card and patient assistance programs remain the most effective ways to reduce out-of-pocket costs.
What to Do Next
If your doctor has prescribed Airsupra, check your insurance formulary for coverage tier and expected copay before filling. Activate the AstraZeneca copay savings card if you have commercial insurance. If you’re uninsured, apply for the AZ&Me Patient Assistance Program immediately and ask your doctor for samples to bridge the processing period. Compare your insurance copay against GoodRx pricing at your preferred pharmacy.
If Airsupra isn’t financially feasible right now, don’t go without a rescue inhaler entirely. Generic albuterol at $25 to $70 remains a safe, effective option for acute bronchospasm — it simply lacks the anti-inflammatory component. Discuss your financial situation openly with your prescriber; they can adjust your overall asthma management plan to optimize what you can afford. Managing healthcare costs effectively requires checking multiple avenues — and with Airsupra, the difference between the worst-case and best-case price is often hundreds of dollars per fill.